Smallcaps.us provided their subscribers with an update regarding their four featured companies: Dynamotive Energy Systems Corporation (OTCBB: DYMTF), Hemispherx Biopharma Inc. (AMEX: HEB), Remedent Inc. (OTCBB: REMI), and Cerus Corp (NASDAQ: CERS).
Last week, Hemispherx Biopharma, Inc. filed its New Drug Application to treat Chronic Fatigue Syndrome. According to data from the Centers for Disease Control, the syndrome might be affecting more than a million people in the United States, not including other nations.
Remedent Inc. increased 41% in approximately three weeks. The remarkable thing to notice is that there was no news announced by the company. Remedent is focused on becoming a world leader in the research, development, manufacturing and marketing of oral care and cosmetic dentistry products.
Dynamotive Energy Systems Corp. announced last week that it has completed a $10.5 million equity financing with an environmentally oriented fund and several other private investors. The President and CEO stated, “The Quercus funding comes at an important time for Dynamotive as this significant cash investment by a sophisticated, alternative-energy-oriented investor provides additional working capital to help speed our progress on major activities currently under way.”
Cerus Corporation’s stock also experienced a large increase the past three weeks as it advanced from $7.23 to $10.18, 40.8%. Cerus is a biopharmaceutical company that develops and commercializes novel, proprietary products in the fields of blood safety and immunotherapy designed to provide safer, more effective medical options to patients in areas of substantial unmet medical needs.
Let us hear your thoughts below: